Clinical trials
Phase 1 Lymphoma, Follicular trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2016 | 1 |
| 2018 | 5 |
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jonsson Comprehensive Cancer Center | 2 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2 |
| University of California, Davis | 2 |
| Assiut University | 1 |
| Cho Pharma Inc. | 1 |
| Garden State Cancer Center at the Center for Molecular Medicine and Immunology | 1 |
| He Huang | 1 |
| Hrain Biotechnology Co., Ltd. | 1 |
| Huazhong University of Science and Technology | 1 |
| Institute for Personal Excellence, P.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 22 |
| Lymphoma, Large B-Cell, Diffuse | 15 |
| Lymphoma, Mantle-Cell | 14 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 11 |
| Burkitt Lymphoma | 9 |
| Lymphoma | 9 |
| Lymphoma, B-Cell, Marginal Zone | 9 |
| Lymphoma, Large-Cell, Immunoblastic | 9 |
| Lymphoma, Non-Hodgkin | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.